ALK TKIs also cause adaptive changes in tumor cells that favor their survival such as the upregulation of Bcl-2 and inhibition of autophagy; therapeutic strategies that target these changes may be effective in the treatment of ALK+ ALCL (56, 77, 79). Here, ALK is linked to anaplastic large cell lymphoma.